Dr. Jill M Wecht, EdD
Claim this profileJames J. Peters VA Medical Center, Bronx, NY
Studies Spinal Cord Injury
Studies Orthostatic Hypotension
7 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Jill M Wecht, EdD is currently running
Spinal Cord Stimulation
for Spinal Cord Injury
The goal of this interventional crossover study is to determine the effects of transcutaneous spinal cord stimulation (TSCS) on the ability to perform moderate exercise and regulate core body temperature in the chronic spinal cord injury community. The main questions it aims to answer are: * What are the effects of active TSCS targeted for BP control on exercise endurance time and HR recovery during submaximal arm cycle ergometry (ACE) as compared to sham TSCS in participants with chronic, cervical SCI? * What are the effects of active TSCS on Tcore responses to cool ambient exposure and on subjective reporting of thermal comfort and thermal sensitivity as compared to sham TSCS. Participants will receive sham and active stimulation while using an arm bicycle or while in a cold room. Participants are free to participate in either the exercise phase, the cold room phase, or both phases of this study. Please note that there no expected long term benefits of this study.
Recruiting0 awards N/A6 criteria
Device-Assisted Exercise
for Spinal Cord Injury
This study aims to determine the effects of transcutaneous spinal cord stimulation to increase blood pressure and use that device to increase power output and heart rate recovery during arm cycle ergometry. In addition, the investigators will see if the stimulation helps regulate body temperature when in a cool environment.
Recruiting0 awards N/A
More about Jill M Wecht, EdD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jill M Wecht, EdD has experience with
- Midodrine Hydrochloride
- DS8R
- Sham Transcutaneous Spinal Cord Stimulation
- Transcutaneous Spinal Cord Stimulation (TSCS)
- Mirabegron
- Placebo
Breakdown of trials Jill M Wecht, EdD has run
Spinal Cord Injury
Orthostatic Hypotension
Low Blood Pressure
High Blood Pressure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jill M Wecht, EdD specialize in?
Jill M Wecht, EdD focuses on Spinal Cord Injury and Orthostatic Hypotension. In particular, much of their work with Spinal Cord Injury has involved treating patients, or patients who are undergoing treatment.
Is Jill M Wecht, EdD currently recruiting for clinical trials?
Yes, Jill M Wecht, EdD is currently recruiting for 4 clinical trials in Bronx New York. If you're interested in participating, you should apply.
Are there any treatments that Jill M Wecht, EdD has studied deeply?
Yes, Jill M Wecht, EdD has studied treatments such as Midodrine Hydrochloride, DS8R, Sham Transcutaneous Spinal Cord Stimulation.
What is the best way to schedule an appointment with Jill M Wecht, EdD?
Apply for one of the trials that Jill M Wecht, EdD is conducting.
What is the office address of Jill M Wecht, EdD?
The office of Jill M Wecht, EdD is located at: James J. Peters VA Medical Center, Bronx, NY, Bronx, New York 10468-3904 United States. This is the address for their practice at the James J. Peters VA Medical Center, Bronx, NY.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.